URI's Center for Vector-Borne Disease (CVBD) is devoted to conducting basic and applied research leading to better strategies for predicting and preventing insect- and arthropod-transmitted infections locally and world-wide. We work on advancing novel concepts like anti-tick vaccine strategies for broad spectrum protection against tick-borne disease. We track diseases like Lyme, Babesiosis, and Anaplasmosis locally, and share our methods to develop similar disease surveillance programs around the world. We evaluate new products and assist others in developing and testing their product concepts. We respond to outbreaks locally and draw on our multi-disciplinary expertise to assist HEALTH at all levels with emerging and re-emerging infectious disease problems.
Insect repellents represent one of the first lines of defense against attacks by blood feeding ticks and the diseases they can transmit. The most common products contain DEET and are applied to skin. An alternative personal-use repellent strategy is to apply repellent or toxicant products (usually permethrin) to clothing or other fabrics rather than directly on the skin.